Simvastatin prevents coronary microvascular remodeling in renovascular hypertensive pigs

被引:53
作者
Zhu, Xiang-Yang
Daghini, Elena
Chade, Alejandro R.
Napoli, Claudio
Ritman, Erik L.
Lerman, Amir
Lerman, Lilach O.
机构
[1] Mayo Clin, Coll Med, Div Nephrol & Hypertens, Dept Internal Med, Rochester, MN 55905 USA
[2] Mayo Clin, Coll Med, Div Cardiovasc Dis, Dept Internal Med, Rochester, MN 55905 USA
[3] Mayo Clin, Coll Med, Dept Physiol & Biomed Engn, Rochester, MN 55905 USA
[4] Univ Naples Federico II, Res Ctr Excellence Cardiovasc Dis, I-80138 Naples, Italy
[5] Univ Naples Federico II, Dept Gen Pathol, I-80138 Naples, Italy
[6] Univ Naples Federico II, Dept Med, I-80138 Naples, Italy
[7] Boston Univ, Evans Dept Med, Boston, MA 02215 USA
[8] Boston Univ, Whitaker Cardiovasc Inst, Boston, MA 02215 USA
来源
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2007年 / 18卷 / 04期
关键词
ENDOTHELIAL GROWTH-FACTOR; TUMOR-NECROSIS-FACTOR; COENZYME-A REDUCTASE; FACTOR-KAPPA-B; EXPERIMENTAL HYPERCHOLESTEROLEMIA; MYOCARDIAL MICROVASCULATURE; CARDIOVASCULAR-DISEASE; OXIDATIVE STRESS; KIDNEY-DISEASE; HEART-FAILURE;
D O I
10.1681/ASN.2006090976
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Patients with hypertension and chronic kidney disease are at risk for cardiovascular diseases, possibly related to inflammation. Statins have beneficial anti-inflammatory effects on vascular structure regardless of cholesterol reduction. It was hypothesized that alterations in myocardial microvascular structure in swine renovascular hypertension (RVH) would be improved by simvastatin treatment. Three groups of pigs were studied after 12 wk: Normal (n = 7), RVH (n = 7), or RVH + simvastatin (RVH + S; 80 mg/d; n = 6). Left ventricular muscle mass and myocardial perfusion were determined in vivo using electron beam computed tomography, and myocardial samples then were scanned ex vivo using micro-computed tomography for measurement of the spatial density of myocardial microvessels (80 to 500 mu m) in situ. Capillary density and myocardial expression of inflammatory and growth factors were determined in myocardial tissue. The effects of simvastatin on inflammation-induced tube formation were evaluated in vitro in human umbilical vein endothelial cells that were exposed to TNF-alpha. RVH and RVH + S had similarly increased arterial pressure and serum creatinine. However, left ventricular hypertrophy was prevented by simvastatin, and myocardial perfusion was increased. Compared with normal, RVH showed increased spatial density of microvessels (169.6 +/- 21 versus 107.7 +/- 15.2 vessels/cm(2); p < 0.05), which was decreased in RVH + S (72.5 +/- 14.9 vessels/cm(2)), whereas capillary density remained similar to normal. RVH also increased myocardial expression of inflammatory and growth factors, which were reversed by simvastatin. Furthermore, simvastatin attenuated TNF-alpha-induced angiogenesis in vitro. Simvastatin prevents myocardial microvascular remodeling and hypertrophy in experimental RVH independent of lipid lowering. This protective effect is partly mediated by blunted expression as well as angiogenic activity of inflammatory cytokines.
引用
收藏
页码:1209 / 1217
页数:9
相关论文
共 56 条
[41]   PREVENTION OF CORONARY HEART-DISEASE WITH PRAVASTATIN IN MEN WITH HYPERCHOLESTEROLEMIA [J].
SHEPHERD, J ;
COBBE, SM ;
FORD, I ;
ISLES, CG ;
LORIMER, AR ;
MACFARLANE, PW ;
MCKILLOP, JH ;
PACKARD, CJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (20) :1301-1307
[42]   Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure [J].
Shiojima, I ;
Sato, K ;
Izumiya, Y ;
Schiekofer, S ;
Ito, M ;
Liao, RL ;
Colucci, WS ;
Walsh, K .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (08) :2108-2118
[43]   Tissue-engineered injectable collagen-based matrices for improved cell delivery and vascularization of ischemic tissue using CD133+progenitors expanded from the peripheral blood [J].
Suuronen, Erik J. ;
Veinot, John P. ;
Wong, Serena ;
Kapila, Varun ;
Price, Joel ;
Griffith, May ;
Mesana, Thierry G. ;
Ruel, Marc .
CIRCULATION, 2006, 114 :I138-I144
[44]  
Takemoto M, 2001, J CLIN INVEST, V108, P1429, DOI 10.1172/JCI200113350
[45]   CORONARY ANGIOGENESIS DURING LONG-TERM HYPERTENSION AND LEFT-VENTRICULAR HYPERTROPHY IN DOGS [J].
TOMANEK, RJ ;
SCHALK, KA ;
MARCUS, ML ;
HARRISON, DG .
CIRCULATION RESEARCH, 1989, 65 (02) :352-359
[46]   Angiogenesis induced by tumor necrosis factor-α is mediated by α4 integrins [J].
Vanderslice P. ;
Munsch C.L. ;
Rachal E. ;
Erichsen D. ;
Sughrue K.M. ;
Truong A.N. ;
Wygant J.N. ;
McIntyre B.W. ;
Eskin S.G. ;
Tilton R.G. ;
Polverini P.J. .
Angiogenesis, 1998, 2 (3) :265-275
[47]   Differential influence of chemokine receptors CCR2 and CXCR3 in development of atherosclerosis in vivo [J].
Veillard, NR ;
Steffens, S ;
Pelli, G ;
Lu, B ;
Kwak, BR ;
Gerard, C ;
Charo, IF ;
Mach, F .
CIRCULATION, 2005, 112 (06) :870-878
[48]   Cerivastatin, an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, inhibits endothelial cell proliferation induced by angiogenic factors in vitro and angiogenesis in in vivo models [J].
Vincent, L ;
Soria, C ;
Mirshahi, F ;
Opolon, P ;
Mishal, Z ;
Vannier, JP ;
Soria, J ;
Hong, L .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (04) :623-629
[49]   Atherosclerotic plaque progression and vulnerability to rupture - Angiogenesis as a source of intraplaque hemorrhage [J].
Virmani, R ;
Kolodgie, FD ;
Burke, AP ;
Finn, AV ;
Gold, HK ;
Tulenko, TN ;
Wrenn, SP ;
Narula, J .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (10) :2054-2061
[50]   Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis [J].
Wanner, C ;
Krane, V ;
März, W ;
Olschewski, M ;
Mann, JFE ;
Ruf, G ;
Ritz, E .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (03) :238-248